Stokes Family Office, LLC Novo Nordisk A S Transaction History

Stokes Family Office, LLC

$854 Million
Q1 2025

A detailed history of Stokes Family Office, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Stokes Family Office, LLC holds 8,439 shares of NVO stock, worth $578,155. This represents 0.07% of its overall portfolio holdings.

Number of Shares

8,439

Previous 8,477 0.45%

Holding current value

$578,155

Previous $729,000 19.62%

% of portfolio

0.07%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$69.3 - $90.95 $2,633 - $3,456	-38 Reduced 0.45%	8,439 $586,000
Q4 2024 Feb 10, 2025	BUY	$85.0 - $120.04 $19,550 - $27,609	230 Added 2.79%	8,477 $729,000
Q2 2024 Jul 05, 2024	BUY	$122.71 - $146.91 $33,377 - $39,959	272 Added 3.41%	8,247 $1.18 Million
Q4 2023 Feb 06, 2024	SELL	$87.78 - $105.45 $153,527 - $184,432	-1,749 Reduced 17.99%	7,975 $825,000
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $435,966 - $956,594	4,794 Added 97.24%	9,724 $884,000
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $35,095 - $38,846	225 Added 4.78%	4,930 $797,000
Q1 2023 May 08, 2023	SELL	$132.34 - $159.14 $50,818 - $61,109	-384 Reduced 7.55%	4,705 $748,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $16,510 - $21,788	161 Added 3.27%	5,089 $688,000
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $13,148 - $16,136	-138 Reduced 2.72%	4,928 $491,000
Q2 2022 Aug 05, 2022	BUY	$103.24 - $121.81 $15,486 - $18,271	150 Added 3.05%	5,066 $565,000
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $17,223 - $20,819	185 Added 3.91%	4,916 $546,000
Q4 2021 Feb 15, 2022	BUY	$95.88 - $117.08 $2,492 - $3,044	26 Added 0.55%	4,731 $530,000
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $10,721 - $13,540	127 Added 2.77%	4,705 $452,000
Q2 2021 Aug 12, 2021	BUY	$67.66 - $84.76 $16,644 - $20,850	246 Added 5.68%	4,578 $384,000
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $30,914 - $34,953	461 Added 11.91%	4,332 $291,000
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $23,628 - $26,051	371 Added 10.6%	3,871 $269,000
Q2 2020 Aug 11, 2020	SELL	$58.54 - $67.94 $2,868 - $3,329	-49 Reduced 1.38%	3,500 $229,000
Q4 2019 Feb 10, 2020	BUY	$49.86 - $58.26 $176,953 - $206,764	3,549 New	3,549 $205,000

Others Institutions Holding NVO

# of Institutions

1,768

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $155B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.

Account

Stokes Family Office, LLC Novo Nordisk A S Transaction History